These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8098976)

  • 1. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
    Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
    Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
    Machin GA
    Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome".
    Coppes MJ; Clericuzio CL
    Med Pediatr Oncol; 1994; 23(4):390. PubMed ID: 8093189
    [No Abstract]   [Full Text] [Related]  

  • 6. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
    Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
    FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
    Bardeesy N; Zabel B; Schmitt K; Pelletier J
    Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
    [No Abstract]   [Full Text] [Related]  

  • 9. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
    Tsuda M; Sakiyama T; Owada M; Chiba Y
    Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel zinc finger mutation in a patient with Denys-Drash syndrome.
    Baird PN; Cowell JK
    Hum Mol Genet; 1993 Dec; 2(12):2193-4. PubMed ID: 8111391
    [No Abstract]   [Full Text] [Related]  

  • 11. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
    Nordenskjöld A; Friedman E; Anvret M
    Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
    Sakai A; Tadokoro K; Yanagisawa H; Nagafuchi S; Hoshikawa N; Suzuki T; Kohsaka T; Hasegawa T; Nakahori Y; Yamada M
    Hum Mol Genet; 1993 Nov; 2(11):1969-70. PubMed ID: 8281164
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
    Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
    Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
    Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome.
    König A; Jakubiczka S; Wieacker P; Schlösser HW; Gessler M
    Hum Mol Genet; 1993 Nov; 2(11):1967-8. PubMed ID: 8281163
    [No Abstract]   [Full Text] [Related]  

  • 16. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.
    Coppes MJ; Huff V; Pelletier J
    J Pediatr; 1993 Nov; 123(5):673-8. PubMed ID: 8229473
    [No Abstract]   [Full Text] [Related]  

  • 17. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
    Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
    Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumour: reconciling genetics and biology.
    Van Heyningen V; Hastie ND
    Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
    Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R
    Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.